Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

BTX Brooklyn ImmunoTherapeutics

0.240
+0.008+3.45%
Close 10/04 16:00 ET
0.250
+0.011+4.38%
Pre Mkt Price 10/05 08:16 ET
High
0.260
Open
0.231
Turnover
72.15K
Low
0.225
Pre Close
0.232
Volume
298.16K
Market Cap
14.09M
P/E(TTM)
Loss
52wk High
10.100
Shares
58.83M
P/E(Static)
Loss
52wk Low
0.210
Float Cap
7.82M
Bid/Ask %
81.82%
Historical High
80.670
Shs Float
32.64M
Volume Ratio
1.01
Historical Low
0.180
Dividend TTM
--
Div Yield TTM
--
P/B
0.95
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.91%
Amplitude
14.97%
Avg Price
0.241
Lot Size
1
Float Cap
7.82M
Bid/Ask %
81.82%
Historical High
80.670
Shs Float
32.64M
Volume Ratio
1.01
Historical Low
0.180
Dividend TTM
--
P/B
0.95
Dividend LFY
--
Turnover Ratio
0.91%
Amplitude
14.97%
Avg Price
0.241
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Brooklyn ImmunoTherapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B. The company is headquartered in San Diego, CA.
CEO: Mr. Matthew Angel
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...